Hasan Mutlu

984 total citations
69 papers, 726 citations indexed

About

Hasan Mutlu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Hasan Mutlu has authored 69 papers receiving a total of 726 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 32 papers in Pulmonary and Respiratory Medicine and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Hasan Mutlu's work include Inflammatory Biomarkers in Disease Prognosis (12 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer Treatment and Pharmacology (7 papers). Hasan Mutlu is often cited by papers focused on Inflammatory Biomarkers in Disease Prognosis (12 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer Treatment and Pharmacology (7 papers). Hasan Mutlu collaborates with scholars based in Türkiye, Germany and United Kingdom. Hasan Mutlu's co-authors include Hasan Şenol Çoşkun, Deniz Tural, Yasemin Benderli Cihan, Hakan Bozcuk, Abdülsamet Erden, Mükremın Uysal, Mustafa Özdoğan, Şeyda Gündüz, Ali Akman and Ertan Yılmaz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and SAE technical papers on CD-ROM/SAE technical paper series.

In The Last Decade

Hasan Mutlu

65 papers receiving 702 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hasan Mutlu Türkiye 16 435 180 116 89 84 69 726
Reuben Broom New Zealand 14 445 1.0× 271 1.5× 242 2.1× 120 1.3× 168 2.0× 35 780
Yaşar Yıldız Türkiye 18 381 0.9× 138 0.8× 107 0.9× 128 1.4× 124 1.5× 67 798
Danielle Desautels Canada 10 562 1.3× 136 0.8× 152 1.3× 82 0.9× 87 1.0× 28 814
Camille Chakiba France 15 370 0.9× 316 1.8× 125 1.1× 79 0.9× 112 1.3× 35 798
Anne-Sophie Veillard Australia 15 261 0.6× 235 1.3× 82 0.7× 118 1.3× 118 1.4× 29 754
Aytuğ Üner Türkiye 15 400 0.9× 189 1.1× 105 0.9× 131 1.5× 182 2.2× 70 786
Hacı Mehmet Türk Türkiye 14 265 0.6× 227 1.3× 54 0.5× 128 1.4× 163 1.9× 75 708
Daan ten Bokkel Huinink Netherlands 15 468 1.1× 501 2.8× 62 0.5× 139 1.6× 149 1.8× 32 1.2k
J. Hense Germany 15 231 0.5× 122 0.7× 42 0.4× 74 0.8× 38 0.5× 56 589
Cheng Fang China 19 409 0.9× 334 1.9× 135 1.2× 177 2.0× 229 2.7× 60 991

Countries citing papers authored by Hasan Mutlu

Since Specialization
Citations

This map shows the geographic impact of Hasan Mutlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hasan Mutlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hasan Mutlu more than expected).

Fields of papers citing papers by Hasan Mutlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hasan Mutlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hasan Mutlu. The network helps show where Hasan Mutlu may publish in the future.

Co-authorship network of co-authors of Hasan Mutlu

This figure shows the co-authorship network connecting the top 25 collaborators of Hasan Mutlu. A scholar is included among the top collaborators of Hasan Mutlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hasan Mutlu. Hasan Mutlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mutlu, Hasan, et al.. (2022). First-line immune-checkpoint inhibitor treatment in extensive-disease small-cell lung cancer: A classical and network meta-analysis. Journal of Cancer Research and Therapeutics. 19(Suppl 1). S6–S11. 4 indexed citations
2.
Bozcuk, Hakan, Hasan Şenol Çoşkun, Sema Sezgin Göksu, et al.. (2021). Prospective external validation of an updated algorithm to quantify risk of febrile neutropenia in cancer patients after a cycle of chemotherapy. Supportive Care in Cancer. 30(3). 2621–2629. 2 indexed citations
3.
4.
Bozcuk, Hakan, et al.. (2020). Checkpoint inhibitors in advanced nonsmall-cell lung cancer; a Bayesian network meta-analysis. Journal of Cancer Research and Therapeutics. 16(4). 828–828. 6 indexed citations
5.
Mutlu, Hasan, et al.. (2018). The importance of stromal and intratumoral tumor lymphocyte infiltration for pathologic complete response in patients with locally advanced breast cancer. Journal of Cancer Research and Therapeutics. 14(3). 619–624. 5 indexed citations
6.
Bozcuk, Hakan, et al.. (2016). A comparative study of art therapy in cancer patients receiving chemotherapy and improvement in quality of life by watercolor painting. Complementary Therapies in Medicine. 30. 67–72. 54 indexed citations
7.
Mutlu, Hasan, et al.. (2015). Metronomic oral chemotherapy with old agents in patients with heavily treated metastatic breast cancer. Journal of Cancer Research and Therapeutics. 11(2). 287–287. 5 indexed citations
8.
Taşdemi̇r, Arzu, Hati̇ce Karaman, Dilek Ünal, & Hasan Mutlu. (2015). Stewart-Treves Syndrome after Bilateral Mastectomy and Radiotherapy for Breast Carcinoma: Case Report. SHILAP Revista de lepidopterología. 11(2). 92–94. 3 indexed citations
9.
Gündüz, Şeyda, Sema Sezgin Göksu, Ali Murat Tatlı, et al.. (2015). Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumab. Molecular and Clinical Oncology. 3(5). 1109–1112. 22 indexed citations
10.
Erden, Abdülsamet, et al.. (2015). The role of blood groups in the development of diabetes mellitus after gestational diabetes mellitus. Therapeutics and Clinical Risk Management. 11. 1613–1613. 16 indexed citations
11.
Mutlu, Hasan & Abdullah Büyükçelik. (2014). The combination of weekly trastuzumab plus vinorelbine may be preferable regimen in HER-2 positive breast cancer patients with brain metastasis. Journal of Oncology Pharmacy Practice. 21(4). 310–312. 6 indexed citations
12.
Mutlu, Hasan, Şeyda Gündüz, Halıt Karaca, et al.. (2014). Second-line gemcitabine-based chemotherapy regimens improve overall 3-year survival rate in patients with malignant pleural mesothelioma: a multicenter retrospective study. Medical Oncology. 31(8). 74–74. 5 indexed citations
13.
Gündüz, Şeyda, Hasan Mutlu, Mükremın Uysal, Hasan Şenol Çoşkun, & Hakan Bozcuk. (2014). Prognostic Value of Hematologic Parameters in Patients with Metastatic Renal Cell Carcinoma Using Tyrosine Kinase Inhibitors. Asian Pacific Journal of Cancer Prevention. 15(8). 3801–3804. 15 indexed citations
14.
Mutlu, Hasan, Abdullah Büyükçelik, Halıt Karaca, et al.. (2013). Secondline Chemotherapy Versus Best Supportive Care in Patient with Malignant Pleural Mesothelioma: A Retrospective Study. Asian Pacific Journal of Cancer Prevention. 14(6). 3887–3889. 5 indexed citations
15.
Mutlu, Hasan, et al.. (2013). Should FISH Test be Performed to all Patients With Breast Cancer?. SHILAP Revista de lepidopterología. 2(2). 539–539. 3 indexed citations
16.
Mutlu, Hasan, et al.. (2013). Is Sunlight a Predisposing Factor for Triple Negative Breast Cancer in Turkey?. Asian Pacific Journal of Cancer Prevention. 14(2). 801–803. 2 indexed citations
17.
Mutlu, Hasan, Abdullah Büyükçelik, Mustafa Kibar, et al.. (2013). Does Sunlight Exposure Improve Survival in Patients with Non-small Cell Lung Cancer?. Asian Pacific Journal of Cancer Prevention. 14(11). 6301–6304. 3 indexed citations
18.
Ayaşan, Tugay, et al.. (2012). The effects of repeated superovulations on the quality of embryo of donor cows and heifers.. 23(1). 11–14.
19.
Mutlu, Hasan, et al.. (2011). Evaluation of Peripheral Blood Smear for Myelodysplasia in Breast Cancer Patients who Received Adjuvant Antracycline. Eurasian Journal of Medicine. 43(3). 173–176. 5 indexed citations
20.
Akman, Ali, Ertan Yılmaz, Hasan Mutlu, & Mustafa Özdoğan. (2008). Complete remission of psoriasis following bevacizumab therapy for colon cancer. Clinical and Experimental Dermatology. 34(5). e202–e204. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Reuben Broom Breakdown of academic impact, for papers by Yaşar Yıldız Breakdown of academic impact, for papers by Danielle Desautels Breakdown of academic impact, for papers by Camille Chakiba Breakdown of academic impact, for papers by Anne-Sophie Veillard Breakdown of academic impact, for papers by Aytuğ Üner Breakdown of academic impact, for papers by Hacı Mehmet Türk Breakdown of academic impact, for papers by Daan ten Bokkel Huinink Breakdown of academic impact, for papers by J. Hense Breakdown of academic impact, for papers by Cheng Fang
Rankless by CCL
2026